|Mr. Peter Crock M.B.A., MBA||Chief Exec. Officer||313.47k||N/A||N/A|
|Mr. Shane Duncan||Chief Operating Officer||287.7k||N/A||N/A|
|Mr. Geoff Aldred||Chief Projects & Information Officer||219.8k||N/A||N/A|
|Ms. Geraldine T. Farrell B.Sc., FCIS, L.L.B., L.L.M.||Chief Compliance Officer & Company Sec.||215.78k||N/A||1970|
|Ms. Deborah Ambrosini||Chief Financial Officer||N/A||N/A||1974|
|Mr. Clive Fanning||Head of Investor Relations||N/A||N/A||N/A|
|Mr. Steven Notaro||Head of Legal||N/A||N/A||N/A|
Cann Group Limited focuses on breeding, cultivating, manufacturing, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Bundoora, Australia.
Cann Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.